Milestone Scientific Inc (MLSS) - Cumulative Company Assets

Public company logo of Milestone Scientific Inc (MLSS)

Milestone Scientific (MLSS) develops computerized systems for comfortable dental anesthesia, displacing traditional syringes through unique pressure control. This chart of the company's total asset value recorded a figure of 8.19. The developer is implementing innovative CompuDent devices and preparing to launch tools for epidural procedures. Meanwhile, the business relies on ESG principles, reducing medication volumes and waste through precision dosing.

Milestone Scientific Inc (MLSS) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Comprehensive metric breakdowns and analytics for Milestone Scientific Corp (MLSS)

- price and consensus price forecast:
Market Chart milestonescientific.com|MLSS - Price Target Chart
- market capitalization data:
Market Valuation Milestone Scientific Corporation|MLSS - Enterprise Value
- book capitalization data:
Net Asset Value per Share Milestone Scientific|MLSS - Book Capitalization|Capitalization to Book Value Ratio milestonescientific.com|MLSS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Milestone Scientific|MLSS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Milestone Scientific Corporation|MLSS - Company Aggregate Debts|Debts to Book Capitalization Milestone Scientific Corporation
Fundamental valuation:milestonescientific.com, MLSS
Manufactured product of Milestone Scientific

Total assets, reverse-calculated via ROA, reflect the aggregate resource potential of the business, where balance sheet dynamics allow investors to differentiate overpayment risks from hidden growth opportunities. By analyzing the total assets chart, one can assess the scaling efficiency of CompuFlo systems and the expansion of B2B distribution in the US, which confirms the fundamental stability of Milestone Scientific (MLSS) as it increases recurring margins.

Main competitors

ISRG (intuitive.com) - Company Total Asset Base|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|MMSI (Merit Medical Systems Inc) - Company Total Assets|Nobel Biocare (NVST) - Cumulative Company Assets|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets XRAY|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets AtriCure Inc ATRC|Cumulative Company Assets STAAR Surgical Corp|Aggregate Asset Value ChromaDex NAGE|Company Total Assets ZIMV (ZimVie Inc.)|ANGO: Company Total Asset Base|Aggregate Company Assets Cerus|TKNO (Alpha Teknova) - Total Business Assets|MGRM: Aggregate Company Assets|Company Total Asset Base Sharps Tech (STSS)|Cumulative Company Assets InfuSystem Holdings|Aggregate Business Assets UTMD (utahmed.com)|Aggregate Company Assets KORU Medical|NYXH - Aggregate Asset Value|Microbot Medical Inc - Cumulative Company Assets|PDEX: Company Total Assets|ZTEK (Zentek Ltd.) - Aggregate Company Assets|elutia.com (ELUT) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|NURO (NeuroMetrix Corp) - Aggregate Company Assets